GO Term | Evidence Code | PMID |
---|---|---|
cell surface receptor signaling pathway | ||
natural killer cell mediated cytotoxicity | ||
immune response-regulating signaling pathway |
GO Term | Evidence Code | PMID |
---|---|---|
plasma membrane |
GO Term | Evidence Code | PMID |
---|---|---|
molecular adaptor activity | ||
amyloid-beta binding |
Gene Ontology |
---|
cell surface receptor signaling pathway |
DO ID | Disease Name | Source |
---|---|---|
DOID:0040086 | Polyomavirus-associated nephropathy | |
DOID:0060704 | lymphoproliferative syndrome | |
DOID:0080600 | COVID-19 | |
DOID:0080827 | human cytomegalovirus infection | |
DOID:12206 | dengue hemorrhagic fever | |
DOID:12365 | malaria | |
DOID:1883 | hepatitis C | |
DOID:2043 | hepatitis B | |
DOID:2048 | autoimmune hepatitis | |
DOID:2366 | West Nile fever |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024